Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
InnoTherapy
Neurophet gears for 2024 IPO after $15M Series C raise and more digital health fundings
By
Adam Ang
|
02:49 am |
November 17, 2023
Also, H2U has received strategic investment to take on the South Korean market.